Pure Global
NCT06154720

Surgical Site Infection After Episiotomy Repair Related to Routine Use of Antibiotic Prophylaxis in Low-Risk Population

Surgical Site Infection Following Episiotomy Repair in Relation to Routine Use of Postpartum Antibiotic Prophylaxis in Low Risk Population: A Randomized Controlled Trial
Ain Shams University·ClinicalTrials.gov·drugCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Surgical Site Infection
Drug/Device/Intervention
Antibiotics
Study type
Observational
Intervention type
drug
Sponsor & location
Primary sponsor
Ain Shams University
Location
Cairo, Egypt
Timeline & enrollment
Phase
N/A
Start date
Sep 10, 2022
End date
Jun 29, 2023
Enrollment
200 participants
Primary outcome

Surgical site infection at site of episiotomy

Summary

Bacterial infections occurring during labor, childbirth, and the puerperium may be associated
 with considerable maternal and perinatal morbidity and mortality. Antibiotic prophylaxis
 might reduce wound infection incidence after an episiotomy, particularly in situations
 associated with a higher risk of postpartum perineal infection, such as midline episiotomy,
 extension of the incision, or in settings where the baseline risk of infection after vaginal
 birth is high. However, available evidence is unclear concerning the role of prophylactic
 antibiotics in preventing infections after an episiotomy.

ICD-10 classifications
Infection following a procedure, not elsewhere classifiedBacterial infection of unspecified siteOther bacterial infections of unspecified siteInfection of obstetric surgical woundOther specified local infections of skin and subcutaneous tissue
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06154720
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06154720 through Pure Global AI's free database. This phase not specified trial is sponsored by Ain Shams University and is currently Completed. The study focuses on Surgical Site Infection. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.